Ledger.Open graph →

SEC Form D · filed November 2, 2016

Novita Pharmaceuticals, Inc

Offering

$3.2M

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NEW YORK, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jue J. Zhang · New York, NYExec · Director David J. Moy · New York, NYExec Chenjian J. Li · New York, NYDirector Christy Y. Shue · New York, NYExec · Director Xin-Yun Y. Huang · New York, NYDirector Daniel Sparks · Stamford, CTExec Justin Mahoney · Stamford, CTExec · Director Kevin Gasvoda · Stamford, CTDirector Tony W. Bartsh · Mt. Pleasant, SCDirector Elliot S. Favus · Mt. Pleasant, SCExec · Director Stephen D. Schroeder · San Francisco, CAExec · Director Passco Parker Manager, LLC · Irvine, CADirector Sacks Ventures GP I, LLC · SAN FRANCISCO, CAExec · Director Passco Parker Depositor, LLC · Irvine, CAExec Richard O. Fortmann · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗